Literature DB >> 15563878

Effect of N-benzoyl-D-phenylalanine and metformin on carbohydrate metabolic enzymes in neonatal streptozotocin diabetic rats.

Natarajan Ashokkumar1, Leelavinothan Pari.   

Abstract

BACKGROUND: The effect of N-benzoyl-D-phenylalanine (NBDP) and metformin was studied on the activities of carbohydrate metabolic enzymes in neonatal streptozotocin (nSTZ) non-insulin-dependent diabetic rats.
METHODS: To induce non-insulin-dependent diabetes mellitus (NIDDM), single dose injection of streptozotocin (STZ; 100 mg/kg body weight; i.p.) was given to 2-day old rats. After 10-12 weeks, rats weighing >150 g were selected for screening in NIDDM model, they were checked for fasting blood glucose concentrations to conform the status of NIDDM. NBDP (50,100 and 200 mg/kg body weight) was administered orally for 6 weeks into the confirmed diabetic rats.
RESULTS: The activities of gluconeogenic enzymes were significantly increased, whereas the activities of hexokinase and glucose-6-phosphate dehydrogenase were significantly decreased in nSTZ diabetic rats. Both NBDP and metformin were able to restore the altered enzyme activities to almost control concentrations. Combination treatment was more effective than either drug alone.
CONCLUSION: The administration of NBDP along with metformin to nSTZ diabetic rats normalizes blood glucose and causes marked improvement of altered carbohydrate metabolic enzymes during diabetes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15563878     DOI: 10.1016/j.cccn.2004.08.011

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  3 in total

1.  Fenugreek attenuation of diabetic nephropathy in alloxan-diabetic rats: attenuation of diabetic nephropathy in rats.

Authors:  Ahmed Amir Radwan Sayed; Mahmoud Khalifa; Fathy Fahim Abd el-Latif
Journal:  J Physiol Biochem       Date:  2012-01-12       Impact factor: 4.158

2.  Negative pressure wound therapy: Regulating blood flow perfusion and microvessel maturation through microvascular pericytes.

Authors:  Zhanjun Ma; Zonghuan Li; Kangquan Shou; Chao Jian; Pengcheng Li; Yahui Niu; Baiwen Qi; Aixi Yu
Journal:  Int J Mol Med       Date:  2017-09-13       Impact factor: 4.101

3.  Chitosan Oligosaccharide Alleviates Abnormal Glucose Metabolism without Inhibition of Hepatic Lipid Accumulation in a High-Fat Diet/Streptozotocin-Induced Diabetic Rat Model.

Authors:  Shing-Hwa Liu; Fan-Wen Chen; Meng-Tsan Chiang
Journal:  Mar Drugs       Date:  2021-06-23       Impact factor: 5.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.